ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS

The results of trials of activity of esomeprazol in children with gastroesophagial reflux disease (gerd) are presented in this article. It was marked that esomeprazol (Nexium) can be used in children of 1–11 years (10 or 20 mg daily) and 12–17 years (20 or 40 mg daily) with gerd according to modern...

詳細記述

書誌詳細
第一著者: R.T. Saygitov
フォーマット: 論文
言語:English
出版事項: "Paediatrician" Publishers LLC 2008-08-01
シリーズ:Вопросы современной педиатрии
オンライン・アクセス:https://vsp.spr-journal.ru/jour/article/view/1441

類似資料